Tag: Food & Drug Administration (FDA)
Senseonics, Ascensia launch one-year CGM system
September 17, 2024HME News Staff
GERMANTOWN, Md., and PARSIPPANY, N.J. – Senseonics and Ascensia Diabetes Care have announced that the U.S. Food and Drug Administration has cleared the next-generation Eversense 365 CGM, the first one-year CGM system. “The approval of Eversense 365 represents a significant leap in CGM innovation,” said Tim Goodnow, PhD, president and CEO of Senseonics. “Extending sensor longevity to a full year, coupled with seamless device connectivity and a high level of accuracy, provides...
CPAP cleaners get warning
September 3, 2024HME News Staff
WASHINGTON – Four companies have received warning letters from the U.S. Food and Drug Administration for selling CPAP cleaning products without marketing clearance or approval, violating the Federal Food, Drug and Cosmetic Act.
The companies are:
Shenzhen Moyeah Intelligent Life Technology Co. for 10 different products, including the CPAP Cleaner With Sanitizer Bag Ozone Disinfector C966 or MOYEAH Brand New CPAP Sanitizer Bag Ozone Disinfector C966|Latest Technology.
Natures...
In brief: Numotion resolves allegations, AdaptHealth taps new exec, FDA strengthens oversight
August 28, 2024HME News Staff
PHOENIX, Ariz. – United Seating and Mobility, d/b/a Numotion, has agreed to pay $13.5 million to resolve allegations that the company violated the federal False Claims Act.
The settlement resolves allegations by the United States that Numotion submitted false claims to Medicare and other federal health care programs for custom wheelchairs and wheelchair parts. According to the allegations, the claims were false because they were based on patient evaluations that were unlawfully...
FDA to strengthen oversight of medical devices
August 26, 2024HME News Staff
WASHINGTON – The Food and Drug Administration has begun building a surveillance system to look for potential safety issues in medical products ranging from surgical masks to implantable pacemakers.
More than 1.7 million injuries and 83,000 deaths over a recent 10-year period in the U.S. have been potentially linked to faulty medical devices, according to a 2018 study by the Government Accountability Office.
Active postmarket surveillance involves the ongoing review of evidence—derived...
FDA grants auth to SoClean device
August 19, 2024HME News Staff
WASHINGTON – The U.S. Food and Drug Administration has granted a marketing authorization to SoClean for its SoClean 3+ bacterial reduction device for use with CPAP accessories (two hoses ResMed ClimateLine Air tubing and SlimLine tubing) and one mask (ResMed Mirage FX mask) for the ResMed AirSense 10 CPAP device. The SoClean 3+ does not replace the cleaning steps recommended by manufacturers of CPAP devices. To date, there are no FDA cleared or approved devices for cleaning, disinfecting or...
FDA to launch Home as a Health Care Hub
May 16, 2024HME News Staff
WASHINGTON – The U.S. Food and Drug Administration is launching Home as a Health Care Hub, an initiative to help reimagine the home environment as an integral part of the health care system, with the goal of advancing health equity for all people in the U.S. The initiative will serve as an idea lab, not only to connect with populations most affected by health inequity, but also for medical device developers, policy makers and providers to begin developing home-based solutions that advance health...
Senators urge GAO to review FDA oversight of recalls
December 14, 2023HME News Staff
WASHINGTON – U.S. Senate Majority Whip Dick Durbin, D-Ill., and U.S. Sen. Richard Blumenthal, D-Conn., have sent a letter to the Government Accountability Office (GAO) calling on the agency to update its 2011 report entitled “Medical Devices: FDA Should Enhance Its Oversight of Recalls” in the wake of the Philips Respironics recall.
The Senators sent the letter following the Pittsburgh Post-Gazette’s and ProPublica’s reporting on the recall of certain...
FDA updates Philips report count
June 6, 2023HME News Staff
AMSTERDAM – The U.S. Food and Drug Administration received more than 6,000 medical device reports (MDRs) associated with the PE-PUR foam degradation in certain recalled Philips CPAP and BiPAP machines and ventilators from Jan. 1, 2023, through March 31, 2023, including 40 reports of death. The MDRs received included both mandatory reports from Philips and voluntary reports from health professionals, consumers, and patients. A wide range of injuries have been reported in these MDRs, including...
In brief: MSC and Trace Medical make buys, FDA extends EUA
March 31, 2023HME News Staff
CLEVELAND – Medical Service Company has acquired OhioHealth Home Medical Equipment in Central Ohio.
“Through its three community locations and several in-hospital offices and liaisons, OhioHealth HME supports lightning-fast discharges for the OhioHealth hospital network,” MSC stated in a press release.
MSC has also entered a long-term partnership with the OhioHealth health system, which comprises a family of 35,000 associates, physicians and volunteers, and a network...
Vivos receives clearance for appliance to treat OSA
January 9, 2023HME News Staff
LITTLETON, Colo. - Vivos Therapeutics, a medtech company focused on developing innovative treatments for patients suffering from obstructive sleep apnea, has received clearance from the U.S. Food and Drug Administration for its proprietary daytime-nighttime (DNA) appliance. With FDA clearance, the DNA appliance offers a new treatment regimen that opens the airway by expanding the palate and training the tongue to rest in the proper position, converting patients to nasal as opposed to oral breathing. ...